XML 31 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2013
Segment Reporting (Tables) [Abstract]  
Segment Reporting Information By Segment
A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:
 
 
Three Months Ended
March 31,
 
(in millions)
 
2013
 
2012*
 
Net sales
 
 
 
 
 
   Interventional Cardiology
 
$
514

 
$
598

 
   Peripheral Interventions
 
194

 
188

 
Cardiovascular
 
708

 
786

 
 
 
 
 
 
 
   Cardiac Rhythm Management
 
485

 
504

 
   Electrophysiology
 
35

 
37

 
Rhythm Management
 
520

 
541

 
 
 
 
 
 
 
   Endoscopy
 
313

 
298

 
   Urology/Women's Health
 
119

 
118

 
   Neuromodulation
 
89

 
83

 
MedSurg
 
521

 
499

 
Net sales allocated to reportable segments
 
1,749

 
1,826

 
Sales generated from divested businesses
 
36

 
29

 
Impact of foreign currency fluctuations
 
(24
)
 
11

 
 
 
$
1,761

 
$
1,866

 
 
 
 
 
 
 
Income (loss) before income taxes
 
 
 
 
 
Cardiovascular
 
$
170

 
$
191

 
Rhythm Management
 
63

 
83

 
MedSurg
 
150

 
133

 
Operating income allocated to reportable segments
 
383

 
407

 
Corporate expenses and currency exchange
 
(70
)
 
(84
)
 
Goodwill and other intangible asset impairment charges; and acquisition-, divestiture-, restructuring-, and litigation related charges or credits
 
(540
)
 
(30
)
 
Amortization expense
 
(103
)
 
(97
)
 
Operating (loss) income
 
(330
)
 
196

 
Other expense, net
 
(64
)
 
(73
)
 
Loss (income) before income taxes
 
$
(394
)
 
$
123

 
* We have restated prior year detail to conform to current year presentation.

 
 
Three Months Ended, March 31,
(in millions)
 
2013
 
2012*
Depreciation expense
 
 
 
 
Cardiovascular
 
$
24

 
$
27

Rhythm Management
 
23

 
23

MedSurg
 
16

 
17

Depreciation expense allocated to reportable segments
 
63

 
67

Corporate expenses and currency exchange
 
(2
)
 
(1
)
 
 
$
61

 
$
66

* We have restated prior year detail to conform to current year presentation.

 
 
As of
(in millions)
 
March 31, 2013
 
December 31, 2012*
Total assets
 
 
 
 
Cardiovascular
 
$
1,539

 
$
1,535

Rhythm Management
 
1,336

 
1,350

MedSurg
 
958

 
967

Total tangible assets allocated to reportable segments
 
3,833

 
3,852

Goodwill
 
5,552

 
5,973

Other intangible assets
 
6,177

 
6,289

All other corporate and manufacturing operations assets
 
1,201

 
1,040

 
 
$
16,763

 
$
17,154

* We have restated prior year detail to conform to current year presentation.